Tapering biologics only likely to work in early disease: expert


The strategy of tapering the doses of biologics in people with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis is only likely to work in early disease, a UK expert has told the limbic. Professor Christopher Edwards, a consultant rheumatologist from the University Hospital Southampton NHS Foundation Trust, UK, was speaking to the limbic following the ...


Already a member? Login to keep reading


OR
© 2017 the limbic